biostudies-literatureUnknown130(15)Verstovsek SNCI NIH HHSBlood1768-1771https://www.ebi.ac.uk/biostudies/studies/S-EPMC5639482biostudies-literatureRuxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results.PMC5639482P30 CA016672Zhen HGranier MCazzola MRambaldi APieri LAssad AKantarjian HMGattoni ERumi EVannucchi AMVerstovsek SPassamonti FBarbui TBarosi GfalseRuxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results.2017-01-01T00:00:00Z2017 Oct2025-04-18T19:03:59.232Z2025-04-07T06:44:16.337ZS-EPMC56394822882741110.1182/blood-2017-02-765032